Abstract: Systems and methods are presented for deploying and using a floating platform using articulated spar legs used as a type of hull, each of the spar legs attached to the floating platform by an articulated connection. Each of the articulated spar legs being moveable from a horizontal to a vertical position, horizontal for transport and vertical for deployment of the floating platform. The articulated spar legs serve to support the floating position of the floating platform. The articulated spar legs are moved from horizontal to vertical position by controlling ballast imposed upon or within spar legs. Each of the articulated spar legs are moveable from a vertical to a horizontal position with a ballast changing method. Systems and methods are presented for extracting natural renewable energy from the environment surrounding the floating platform with energy capture devices modularly affixed to the platform and energy capture devices incorporated into the articulated spar legs.

Abstract: Systems and methods are presented for deploying and using a floating platform using articulated spar legs used as a type of hull, each of the spar legs attached to the floating platform by an articulated connection. Each of the articulated spar legs being moveable from a horizontal to a vertical position, horizontal for transport and vertical for deployment of the floating platform. The articulated spar legs serve to support the floating position of the floating platform. The articulated spar legs are moved from horizontal to vertical position by controlling ballast imposed upon or within spar legs. Each of the articulated spar legs are moveable from a vertical to a horizontal position with a ballast changing method. Systems and methods are presented for extracting natural renewable energy from the environment surrounding the floating platform with energy capture devices modularly affixed to the platform and energy capture devices incorporated into the articulated spar legs.

Abstract: The present invention relates to uses of granulocyte colony stimulating factor (GCSF) or fragment thereof for the preparation of a pharmaceutical composition for treating organ dysfunction caused by ischemia, whereby the pharmaceutical composition is to be administered to a patient who is subjected to a surgical or interventional procedure in order to improve organ function, to improve organ function, to improve blood flow and/or to induce revascularization. Furthermore, the present invention relates to methods of treating organ dysfunction caused by ischemia comprising administering a therapeutically effective amount of G-CSF or fragment thereof to a patient who is subjected to a surgical or interventional procedure in order to improve organ function, to improve organ function, to improve blood flow and/or to induce revascularization.